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Total hip bone mass predicts survival in chronic hemodialy- elderly women have found that reduced bone mass is
sis patients. also predictive of increased all-cause mortality and car-
Background. Bone mass measurements are widely used to diovascular mortality, although the mechanism of thisdiagnose osteoporosis and identify patients at risk for fractures.
association is not clear [1, 2]. Among patients on chronicRecent studies have shown that reduced bone mass is also
predictive of all-cause and cardiovascular mortality in healthy hemodialysis, bone mass may be reduced due to a com-
postmenopausal women. Among chronic hemodialysis patients bination of age-related or postmenopausal bone loss,
reduced bone mass resulting from the combined effects of age- and renal osteodystrophy [3, 4]. Evidence is now accumu-related factors and renal osteodystrophy has been associated
lating that factors involved in renal osteodystrophy maywith vascular calcification. In this prospective study, we investi-
gated the ability of bone mass measurements to predict mortal- also be important in the pathogenesis of cardiovascular
ity in chronic hemodialysis patients. complications among chronic dialysis patients. In one
Methods. Eighty eight patients underwent hip bone mass mea- study, the rate of reduction of bone mineral contentsurements by dual energy x-ray absorptiometry (DEXA) and
was identified as an independent determinant of vascularwere followed up for a mean of 3.5 years. Eleven patients
calcification [3] and in others, elevations in serum cal-received renal transplants and were therefore excluded. Forty
of the remaining patients died, predominantly due to cardiovas- cium x phosphate product (Ca x P) were associated with
cular causes (43%). coronary artery calcification [5] or an increased risk of
Result. Cox regression analysis showed patient age, osteopo-
death on dialysis [6, 7]. Since cardiovascular disease isrosis or osteopenia, and baseline average calcium x phosphate
the single most common cause of death among dialysisproduct (Ca x P) to be independently predictive of increased
mortality. Patients with osteopenia or osteoporosis had a 3.3- patients, these findings suggest that bone disease may
and 4.3-fold increased risk of death, respectively. A Ca x P of also impact on survival in dialysis patients. In a previous
5.0 mmol2/L2 predicted a threefold increased risk of death. cross-sectional study, we identified age, serum parathy-Previous renal transplantation predicted a lower mortality.
roid hormone (PTH) levels, gastric acid suppressionConclusions. This study has shown for the first time that
reduced total hip bone mass is an independent predictor of therapy, female gender, age at menarche, and a history
all-cause mortality among chronic hemodialysis patients. Our of previous fractures as important negative determinants
findings suggest that reduced bone mass and elevated Ca x P of bone mass in chronic hemodialysis patients [4]. In the
may be involved in the pathogenesis of cardiovascular disease
present paper, we present the results of a 3-year follow-in these patients but further research is required to investigate
up study showing that reduced total hip bone mass isthe possible mechanisms for these associations.
an independent predictor of all-cause mortality among
these patients.
The measurement of bone mass is widely used to diag-
nose osteoporosis and thereby identify patients at in-
METHODScreased risk for fractures. Recently several studies in
Patients
All 88 chronic hemodialysis patients who were origi-Key words: bone mass, calcium, haemodialysis, osteopenia, osteoporo-
sis, phosphate. nally recruited into a study of risk factors for reduced
bone mass [4] were included in a follow-up phase. At
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Table 1. Causes of death among 40 chronic hemodialysis patientswere therefore excluded from the study. The remaining
who died during 3.5 years of follow-up
77 patients were followed up for approximately 3 years
Cause Number %(June 1997 to November 2000). All patients received di-
Cardiovascular 17 42.5alysis three times per week and dialyzers were not re-
Sepsis 10 25.0used. Seven patients had suffered fractures prior to inclu-
Stopped/suicide 5 12.5
sion into the study (one hip, one clavicle, two wrists, one Malignancy 4 10.0
Unknown 2 5.0ankle, one fibula, and one toe). All but one of these had
Gastrointestinal bleed 1 2.5osteopenia or osteoporosis. Six patients had had parathy-
Chronic obstructive pulmonary disease 1 2.5
roidectomy prior to the study and a further four under-
went surgery during follow-up. No patients received spe-
cific treatment for osteoporosis.
bone mass measurements were used to diagnose osteope-
Data collection
nia or osteoporosis in this study.
Collection of demographic data, treatment details, and The study was approved by the Nottingham City Hos-
cause of death was performed by review of case notes and pital Research Ethics Committee and all patients gave
treatment records. The weight used for the calculation of informed consent prior to entry into the study.
body mass index was the average of three postdialysis
weights recorded in the week prior to entry. Analysis
Group data are expressed as mean  SD. Differences
Biochemistry
between independent groups of patients were assessed
Serum urea, creatinine, albumin, calcium, and phos- using an unpaired t test (for continuous data) or a Chi-
phate were measured using standard autoanalyser tech- squared test (for categorical data). Cox proportional haz-
niques. Calcium levels were corrected for albumin con- ards analysis with stepwise entry of independent vari-
centration. Average Ca x P product was calculated using ables was employed to examine the effect of baseline
the average calcium and phosphate levels (measured ev- characteristics on the subsequent survival of patients. P
ery 2 months) over 1 year prior to entry. Urea reduction values of0.05 were considered to be significant. Analy-
ratio (URR) was calculated using urea levels before and ses were performed using SPSS 9.0 for Windows.
after dialysis. Intact PTH levels were measured within 6
months of entry into the study using a radioimmunoassay
RESULTS(Incstar, Atlantic Antibodies; normal range for PTH 
10 to 55 ng/L). From January 24, 1997, this was changed Forty patients died during a mean follow-up period
of 3.5 years and the causes of death are shown in Ta-to a chemiluminescent enzyme immunometric assay per-
formed with an automated analyzer (Immulite, Diagnos- ble 1. A univariate analysis of deceased versus surviving
patients with respect to variables thought to be predictivetic Products Corporation; normal range for PTH  12
to 72 ng/L). Results from the latter assay were converted for increased mortality in chronic hemodialysis patients
on the basis of previous studies or biological plausibilityto make them comparable to results from the previous
assay using a formula developed and validated by the is shown in Table 2. Deceased patients were significantly
older, had a lower prevalence of previous renal allograft,Clinical Chemistry laboratory at City Hospital.
and a higher prevalence of osteopenia or osteoporosis
Bone densitometry than surviving patients at baseline.
Cox proportional hazards analysis using all of the fac-Dual energy x-ray absorptiometry (DEXA) studies of
the lumbar spine and left hip (or right hip if this was not tors shown in Table 2 as independent variables, identified
age, history of previous renal allograft, average Ca x P,possible for technical reasons) were performed by the
Radiology Department at City Hospital using a Lunar and osteopenia or osteoporosis (as defined by total hip
bone mass) as significant, independent predictors of mor-Expert-XL densitometer (Lunar Corporation). This mea-
sures bone mass in g/cm2. Results are reported as actual tality. Further analysis with patients divided into differ-
ent categories for age indicated a significant increase invalues obtained as well as T and Z scores, which reflect
the number of SDs by which a patient’s value differs mortality for patients in the 65 to 74.9 years and 75 years
or older categories versus the younger than 40 years cat-from the mean of a group of young normal or age- and
sex-matched controls, respectively. Thus a T score of egory but no significant increase in the 40 to 64.9 years
of age category (Fig. 1). Similar analysis with patients2.5 represents a bone mass value 2.5 SDs below the
mean of a young normal population. The World Health divided into categories for Ca x P showed a significant
increase in mortality for those in the 5.0 to 5.49 mmol2/L2Organization has defined osteoporosis in terms of T score
criteria. Osteopenia is defined as a T score of between and5.50 mmol2/L2 categories versus the3.64 mmol2/L2
category (below the upper limit of the reference range),1.0 and 2.5 and osteoporosis as 2.5 [8]. Total hip
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Table 2. Univariate analysis of deceased versus surviving patients
with respect to variables thought to be predictive of increased
mortality in chronic hemodialysis patients
Surviving Deceased
Risk factor (N  37) (N  40) P value
Age years 51.315.7 69.511.0 0.001
Male Sex 19 (51.4%) 21 (52.5%) 0.9
Caucasian 27 (72.9%) 36 (90%) 0.05
Cardiovascular disease 7 (18.9%) 14 (35.0%) 0.1
Diabetes mellitus 4 (10.8%) 5 (12.5%) 0.8
Bone mass index kg/m2 24.45.1 23.83.8 0.6
Time on dialysis months 6358 5154 0.4
Previous allograft 13 (35.1%) 1 (2.5%) 0.001
Serum albumin g/L 314 314 0.6
Hemoglobin g/dL 9.71.5 9.91.5 0.6
Serum ferritin lg/L 357215 498383 0.05
Serum phosphate mmol/L 1.950.74 1.830.53 0.4
Parathyroid hormone ng/L 220224 226202 0.9
Calcium x phosphate mmol 2/L2 4.71.3 4.71.0 0.9
Urea reduction ratio % 668 658 0.4
Osteopenia 15 (40.5%) 19 (47.5%) 0.03
Osteoporosis 2 (5.4%) 9 (22.5%) 0.03
Fig. 2. Graph showing the independent effect of baseline average cal-
cium x phosphate (Ca x P) product (in mmol2/L2) on survival over time
among chronic hemodialysis patients. Symbols of Ca x P are: (), greater
than 5.50; (), 5.00 to 5.49; (), 3.65 to 4.99; (), less than 3.64.
Fig. 1. Graph showing the independent effect of age on survival over
time among chronic hemodialysis patients. Symbols are: (), older than
75 years old; (), 65 to 74.9 years old; (), 40 to 64.9 years old; (),
younger than 40 years old.
Fig. 3. Graph showing the independent effect of osteoporosis () or
osteopenia () on survival over time among chronic hemodialysis pa-
tients. (), normal.
but no significant increase in the 3.65 to 4.99 mmol2/L2
category (Fig. 2). The presence of osteopenia or osteopo-
rosis (defined by total hip bone mass T scores) indepen-
dently predicted a greater risk of death versus those with osteopenia or osteoporosis were each associated with
substantial increases in the risk of death, whereas a his-normal bone mass (Fig. 3). In the final model, age and
Ca x P were included as a categorical variables with tory of previous allograft was predictive of a substantially
lower hazard of death (Table 3). Owing to the large dif-patients divided into younger than 65 years or 65 years
or older and5.0 or5.0 mmol2/L2, respectively. Patient ference in survival between patients who had previously
received a renal transplant and those who had not, theage 65 years or older, Ca x P product5.0 mmol2/L2, and
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Table 3. Cox proportional hazards analysis of factors predicting or postmenopausal bone loss and renal osteodystrophy
mortality among chronic hemodialysis patients
[3, 4]. Moreover, it is now becoming evident that bone
Relative hazard disease may have important implications for the well-
Variable (95% CI) P value being of dialysis patients, beyond the simple loss of bone
Age 65 years 4.07 (1.96–8.41) 0.0002 mass. Several studies have suggested that factors associ-
Osteopenia 3.33 (1.54–7.19) 0.002
ated with bone disease among dialysis patients may alsoOsteoporosis 4.27 (1.71–10.64) 0.002
Calcium x phosphate play a role in cardiovascular disease. The annual rate of
product 5.0 mmol 2/L2 3.00 (1.49–6.03) 0.002 change in bone mineral content [3], serum alkaline phos-
Previous allograft 0.06 (0.01–0.45) 0.007
phatase levels [5], and Ca x P [5, 10] have each been
associated with vascular calcification, a known risk fac-
tor for cardiovascular events in the general population
[11–13]. Furthermore, in patients with chronic renal fail-Cox proportional hazards analysis was repeated with
ure both low bone turnover (adynamic bone disease)the previously transplanted group excluded. The results
and high bone turnover (hyperparathyroidism) are asso-were very similar to those from the original analysis and
ciated with reduced bone mass and increased risk ofpatient age 65 years or older, Ca x P5.0 mmol2/L2, and
metastatic calcification. Small vessel calcification, which,osteopenia or osteoporosis were confirmed as indepen-
in the past was associated with severe secondary hyper-dent risk factors for decreased survival (data not shown).
parathyroidism, is now also associated with adynamic boneNo new variables entered the equation as risk factors.
disease [14]. Our data show for the first time that osteo-Reanalysis of data using lumbar spine bone mass to
penia or osteoporosis is a significant independent pre-define osteopenia or osteoporosis did not identify os-
dictor of mortality in hemodialysis patients. Due to theteopenia/osteoporosis as a significant predictor of sur-
relatively small number of patients, we were unable tovival (data not shown).
analyse directly the possible associations between bone
mass and cardiovascular mortality. Cardiovascular disease
DISCUSSION was, however, the single largest cause of death among
our patients, suggesting that an association with vascularThis prospective study highlights an important new
finding, specifically, that a single total hip bone mass mea- disease may account at least in part for the association
between reduced bone mass and increased mortality. Onsurement predicts all-cause mortality in chronic hemodi-
alysis patients, independent of age, and other previously the other hand, it remains possible that bone mass acted
as a marker of general health status or other factors af-identified predictors of mortality. Patients with osteope-
nia or osteoporosis had a 3.3- and 4.3-fold increased risk fecting mortality as suggested by the substantial propor-
tion of deaths due to sepsis, malignancy, and withdrawalof death respectively, during the approximately 3 years
of follow-up. These findings are consistent with the re- from dialysis.
The lack of an association between lumbar spine bonesults of previous studies in postmenopausal women that
observed a 1.19-fold increase in risk of nontrauma mor- mass measurements and mortality was not unexpected.
Previous studies have shown that spinal osteophytes andtality for each 1 SD decrease in age-adjusted proximal
radius bone mass [1] or a relative risk of 1.4 for all-cause abdominal aortic calcification may spuriously elevate
lumbar bone mass measurements and therefore obscuremortality for each 1 SD decrease in age-adjusted distal
forearm bone mass [2]. Similarly, others found that each any associations with other factors [15].
Our results confirm the previously described associa-1 SD increase in the rate of bone loss at the hip over a
5.7-year period predicted a 1.3-fold increase in all-cause tion between elevated Ca x P and increased mortality
in hemodialysis patients [6]. The previous study found amortality in women 65 years or older [9]. Several expla-
nations have been offered for these somewhat unex- trend towards an increased mortality above the reference
range, although significantly increased mortality was seenpected associations. It has been proposed that reduced
bone mass is a marker of the net effect of general health only at levels 6 mmol2/L2. We have shown an increase
in mortality with Ca x P5 mmol2/L2. Although the exactstatus and other variables that affect mortality [1]. On the
other hand, the association of reduced bone mass with reasons for this association remain to be elucidated, re-
cent studies showing an association between elevationsincreased risk of death from stroke [1], coronary heart
disease [9], or combined cardiovascular mortality [2] sug- in Ca x P and coronary artery calcification, a risk factor
for cardiovascular events [5], suggest that vascular calci-gests a specific association with vascular disease. Dys-
regulation of matrix protein expression resulting in ab- fication is a likely mechanism. Since renal osteodystro-
phy is associated with elevations in Ca x P, it is possiblenormal calcification of bone and blood vessels is one
mechanism proposed to account for this association [9]. that this also is one of the mechanisms whereby low
bone mass may be associated with increased mortality,Among chronic hemodialysis patients, bone disease may
be compounded by the combined effects of age-related particularly that due to cardiovascular disease. Together,
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maceuticals for help toward funding the dual-energy x-ray (DEXA)these data suggest that maintaining the Ca x P below 5
scans. The authors gratefully acknowledge advice as regards statisti-mmol 2/L2 may result in a lower risk of cardiovascular cal analysis received from Dr J. Pearson of the Department of Public
risk. This hypothesis should now be tested in prospective Health Medicine and Epidemiology, University of Nottingham Medical
School.clinical studies.
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